Moderna Inc will supply 12 million doses of its COVID-19 shot adapted to target the Omicron variant of the coronavirus to Canada, the company said on Monday.
Tag Archive for: pandemic
For our 40th Anniversary Edition, we asked our editorial advisory board members to talk about the most significant strides they’ve seen over the course of their careers, how client challenges have changed, thoughts on talent and recruitment strategies, and trends that are advancing the industry. Obviously one of the biggest changes has been the role of digital technology and its part in personalization. But frankly, we barely scratched the surface!
Panacell Biotech plans to initiate a program to investigate the use of natural killer (NK) immune cells, exosomes and brown adipose-derived stem cells to treat Long COVID.
Gilead’s total revenue for Q2 increased 1% to $6.3 billion compared to Q2 in 2021. Overall, the company exceeded both its own expectations and the predictions of market analysts for the second quarter.
‘Living with COVID’: Where the pandemic could go next By Jennifer Rigby and Julie Steenhuysen LONDON/CHICAGO, Aug 1 (Reuters) – As the third winter of the coronavirus pandemic looms in […]
Scientists around the world are working to expand the knowledge base and the U.S. government is ramping up testing and vaccine availability.
Dr Anthony Fauci, an infectious disease expert who is the chief medical adviser to U.S. President Joe Biden, will retire by the end of Biden’s term, he told Politico in an interview on Monday.
Providers continue to adapt to the new care models to patients’ needs. As the pandemic wreaked havoc across the United States, healthcare providers started deploying various health IT solutions to address emerging challenges. They aimed to reduce the load on doctors and protect clinicians and patients from the virus exposure.
As per the modified supply agreement with the government, Lilly will provide an additional 150,000 doses of bebtelovimab for about $275 million. The drug has also shown effectiveness against the Omicron variant.
Late-stage data on an experimental COVID-19 vaccine from Sanofi and GSK has showed the shot confers protection against the Omicron variant of the virus, the companies said. The so-called bivalent vaccine targets the Beta variant – first identified in South Africa – as well as the original Wuhan strain of the virus.